Form 4 for SHPH Shuttle Pharmaceuticals Holdings, Inc.

Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-29 · accession 0001493152-23-000319 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-01-04	2022-12-29	SHPH	Adkins William	Former Dir	S - Sale	$1.61	-995	184.1K	-0.5%	-$1,602
D	2023-01-04	2022-09-02	SHPH	Adkins William	Former Dir	J - Other	—	+138.9K	138.9K	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	COMMON STOCK	2022-12-29	S	D	995	$1.61	184,071	D	—	—	(F1) Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. (F2) Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust").
2	Derivative	WARRANTS (right to buy)	2022-09-02	J	A	138,889	—	138,889	D	$4.00 · 2022-09-02 to 2025-09-02	138,889 Common Stock	(F3) Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.